These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 39363015)

  • 1. SLC45A4 is involved in malignant progression of ovarian cancer through glycolytic metabolic reprogramming.
    Xu Y; Han X; You S; Zhu W; Zhang M; Lu C; He J; Yao Q
    Sci Rep; 2024 Oct; 14(1):23031. PubMed ID: 39363015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.
    Chen Y; Liu L; Xia L; Wu N; Wang Y; Li H; Chen X; Zhang X; Liu Z; Zhu M; Liao Q; Wang J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):44. PubMed ID: 35101076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma.
    Chen W; Huang F; Huang J; Li Y; Peng J; Zhuang Y; Huang X; Lu L; Zhu Z; Zhang S
    J Gene Med; 2021 Sep; 23(9):e3364. PubMed ID: 34010493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
    Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
    Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
    Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
    J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCEB2/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis.
    Deng Z; Li B; Wang W; Xia W; Zhang L; Chen L; Jin W
    Eur J Med Res; 2024 Sep; 29(1):456. PubMed ID: 39261917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironment.
    Zhang J; Ouyang F; Gao A; Zeng T; Li M; Li H; Zhou W; Gao Q; Tang X; Zhang Q; Ran X; Tian G; Quan X; Tang Z; Zou J; Zeng Y; Long Y; Li Y
    Mol Cancer; 2024 May; 23(1):94. PubMed ID: 38720298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.
    Nan Y; Wu X; Luo Q; Chang W; Zhao P; Zhang L; Liu Z
    Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315348121. PubMed ID: 38701117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BBOX1 mediates metabolic reprogramming driven by hypoxia and participates in the malignant progress of high-grade serous ovarian cancer.
    Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
    Biochim Biophys Acta Mol Cell Res; 2024 Dec; 1871(8):119830. PubMed ID: 39181218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium selenite inhibits cervical cancer progression via ROS-mediated suppression of glucose metabolic reprogramming.
    Zeng Q; Lv C; Qi L; Wang Y; Hao S; Li G; Sun H; Du L; Li J; Wang C; Zhang Y; Wang X; Ma R; Wang T; Li Q
    Life Sci; 2024 Nov; 357():123109. PubMed ID: 39384146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer.
    Xia L; Sun J; Xie S; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Sha J; Xue W
    Cell Prolif; 2020 Nov; 53(11):e12918. PubMed ID: 33025691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts.
    Radhakrishnan R; Ha JH; Jayaraman M; Liu J; Moxley KM; Isidoro C; Sood AK; Song YS; Dhanasekaran DN
    Cancer Lett; 2019 Feb; 442():464-474. PubMed ID: 30503552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00629, a HOXB4-downregulated long noncoding RNA, inhibits glycolysis and ovarian cancer progression by destabilizing c-Myc.
    Liu J; Zhu Y; Wang H; Han C; Wang Y; Tang R
    Cancer Sci; 2024 Mar; 115(3):804-819. PubMed ID: 38182548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MARCH5 promotes aerobic glycolysis to facilitate ovarian cancer progression via ubiquitinating MPC1.
    Xu Y; Zhao S; Shen Y; Li Y; Dang Y; Guo F; Chen Z; Li J; Yang H
    Apoptosis; 2024 Aug; 29(7-8):1232-1245. PubMed ID: 38615083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isocitrate dehydrogenases 2-mediated dysfunctional metabolic reprogramming promotes intestinal cancer progression via regulating HIF-1A signaling pathway.
    Liu S; Zhou Y; Chen Y; Qiao Y; Bai L; Zhang S; Men D; Zhang H; Pan F; Gao Y; Wang J; Wang Y
    Int Immunopharmacol; 2024 Oct; 140():112828. PubMed ID: 39094359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
    Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
    Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting gastric cancer progression.
    Zhao H; Jiang R; Feng Z; Wang X; Zhang C
    J Transl Med; 2023 Nov; 21(1):833. PubMed ID: 37980488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1.
    Ma Y; Zong H; Pan P; Shang H; Yang X
    Exp Cell Res; 2024 May; 438(1):114006. PubMed ID: 38599542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
    Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M
    Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.